Priority Date: 24.05.16 (WO 2016CN83124)

HETEROCYCLIC INHIBITORS OF CBP/EP300 AND THEIR USE IN THE TREATMENT OF CANCER

  • Application ID: EP17728375
  • Status: Request for examination was made

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Mewburn Ellis LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 226 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 24.05.2016 - Priority Date (WO 2016CN83124)
  • 30.11.2017 - Publication A2 (WO2017205536)
  • 10.04.2019 - Publication A2 (EP3464270)